Esperion Therapeutics, Inc. (ESPR)

NASDAQ: ESPR · Real-Time Price · USD

2.220

+0.050 (2.30%)

At close: Apr 13, 2026, 4:00 PM EDT

2.224

+0.004 (0.16%)

After-hours: Apr 13, 2026, 7:57 PM EDT

Esperion Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	403.14	332.31	116.33	75.48	78.45
Revenue Growth (YoY)	21.31%	185.66%	54.14%	-3.79%	-65.53%
Cost of Revenue	129.22	68.6	43.27	26.97	14.22
Gross Profit	273.91	263.71	73.07	48.51	64.23
Selling, General & Admin	165.79	163.07	142.52	109.08	184.99
Research & Development	47.85	46.24	86.11	118.93	105.98
Total Operating Expenses	213.64	209.31	228.63	228.01	290.96
Operating Income	60.27	54.4	-155.56	-179.5	-226.73
Interest Expense	-84.6	-59.25	-58.98	-56.81	-46.35
Other Non-Operating Income (Expense)	3.49	-46.9	5.29	2.65	3.98
Total Non-Operating Income (Expense)	-81.11	-106.15	-53.69	-54.16	-42.38
Pretax Income	-20.84	-51.75	-209.25	-233.66	-269.11
Provision for Income Taxes	1.84	-	-	-	-
Net Income	-22.68	-51.75	-209.25	-233.66	-269.11
Net Income to Common	-22.68	-51.75	-209.25	-233.66	-269.11
Shares Outstanding (Basic)	208	187	103	66	29
Shares Outstanding (Diluted)	208	187	103	66	29
Shares Change (YoY)	11.05%	81.54%	55.27%	129.76%	5.20%
EPS (Basic)	-0.11	-0.28	-2.03	-3.52	-9.31
EPS (Diluted)	-0.11	-0.28	-2.03	-3.52	-9.31
Shares Outstanding	245.22	195.85	118.21	74.57	60.88
Free Cash Flow	-13.09	-23.97	-135.49	-174.83	-263.81
Free Cash Flow Per Share	-0.06	-0.13	-1.31	-2.63	-9.13
Gross Margin	67.95%	79.36%	62.81%	64.27%	81.88%
Operating Margin	14.95%	16.37%	-133.72%	-237.83%	-289.02%
Profit Margin	-5.63%	-15.57%	-179.87%	-309.58%	-343.04%
FCF Margin	-3.25%	-7.21%	-116.46%	-231.64%	-336.29%
EBITDA	60.38	54.47	-155.4	-179	-226.12
EBITDA Margin	14.98%	16.39%	-133.58%	-237.17%	-288.24%
EBIT	60.27	54.4	-155.56	-179.5	-226.73
EBIT Margin	14.95%	16.37%	-133.72%	-237.83%	-289.02%
Effective Tax Rate	-8.83%	0.00%	0.00%	0.00%	0.00%

Updated Mar 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q